On 2025-05-06, Cogent Biosciences, Inc. (COGT) announced earnings per share of $-0.52 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.56.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.54 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.56 | $-0.52 |
| 2025-02-25 | 2024-12-31 | $-0.59 | $-0.09 |
| 2024-11-12 | 2024-09-30 | $-0.55 | $-0.64 |
| 2024-08-06 | 2024-06-30 | $-0.55 | $-0.59 |
| 2024-05-07 | 2024-03-31 | $-0.50 | $-0.62 |
| 2024-02-26 | 2023-12-31 | $-0.54 | $-0.63 |
| 2023-11-02 | 2023-09-30 | $-0.50 | $-0.64 |
| 2023-08-08 | 2023-06-30 | $-0.53 | $-0.59 |
| 2023-05-09 | 2023-03-31 | $-0.58 | $-0.54 |
| 2023-03-14 | 2022-12-31 | $-0.50 | $-0.56 |
| 2022-11-14 | 2022-09-30 | $-0.51 | $-0.50 |
| 2022-08-09 | 2022-06-30 | $-0.64 | $-0.71 |
| 2022-05-10 | 2022-03-31 | $-0.53 | $-0.68 |
| 2022-03-15 | 2021-12-31 | $-0.55 | $-0.61 |
| 2021-11-10 | 2021-09-30 | $-0.43 | $-0.48 |
| 2021-08-16 | 2021-06-30 | $-0.39 | $-0.43 |
| 2021-05-12 | 2021-03-31 | $-0.46 | $-0.34 |
| 2021-03-16 | 2020-12-31 | $-0.30 | $-6.03 |
| 2020-11-09 | 2020-09-30 | $-0.76 | $-1.04 |
| 2020-08-11 | 2020-06-30 | $-0.84 | $-0.96 |
| 2020-05-11 | 2020-03-31 | $-1.32 | $-0.80 |
| 2020-03-26 | 2019-12-31 | $-1.40 | $0.28 |
| 2019-11-12 | 2019-09-30 | $-1.24 | $-1.56 |
| 2019-08-12 | 2019-06-30 | $-1.56 | $-1.36 |
| 2019-05-13 | 2019-03-31 | $-1.24 | $-1.56 |
| 2019-03-28 | 2018-12-31 | $-1.36 | $-1.16 |
| 2018-11-12 | 2018-09-30 | $-1.40 | $-1.36 |
| 2018-08-13 | 2018-06-30 | $-1.32 | $-1.24 |
| 2018-05-14 | 2018-03-31 | $-1.40 | $-2.64 |